Showing 731-740 of 1614 results for "".
- Aura Biosciences Names Mark De Rosch, PhD, Chief Operating Officerhttps://modernod.com/news/aura-biosciences-names-mark-de-rosch-phd-chief-operating-officer/2479008/Aura Biosciences announced the appointment of Mark De Rosch, PhD, as Chief Operating Officer. In his role, he will be responsible for leading Aura’s global operations and regulatory strategy. Dr. De Rosch brings to Aura more than 30 years of experience in leading global regulatory and deve
- Norlase Receives CE Mark Approval for LION Green Laser Systemhttps://modernod.com/news/norlase-receives-ce-mark-approval-for-lion-green-laser-system/2478718/Norlase announced that it has been granted the European CE Mark for the LION green laser system. LION combines the Keeler Vantage Plus diagnostic indirect with Norlase’s compact laser technology into one device. With LION’s untethered and portable design, physicians can move freely between treatm
- Lacrivera Announces CE Mark of the Vera180 Synthetic Absorbable Lacrimal Plughttps://modernod.com/news/lacrivera-announces-ce-mark-of-the-vera180-synthetic-absorbable-lacrimal-plug/2478063/Lacrivera announced CE Mark approval for the Vera180 synthetic absorbable lacrimal plug. The Vera180 provides extended temporary occlusion lasting approximately 180 days and is ideal for treatment of post-surgical dry eye and for treating the dry eye components of various ocular surface diseases,
- SightGlass Vision Granted CE Mark for Eyeglasses That Slow Myopia Progression in Childrenhttps://modernod.com/news/sightglass-vision-granted-ce-mark-for-novel-eyeglasses-that-slow-myopia-progression-in-children/2477859/SightGlass Vision announced it has achieved CE Mark approval for its first product – novel eyeglasses designed to slow the progression of myopia in children. The approval allows the SightGlass Vision to commercialize its suite of Diffusion Optics Technology (DOT) products across the EU,
- Sonoma Pharmaceuticals Announces New CE Marking for Microdacyn60 Eye Carehttps://modernod.com/news/sonoma-pharmaceuticals-announces-new-ce-marking-for-microdacyn60-eye-care/2477833/Sonoma Pharmaceuticals has announced that it received a new CE Marking for its Microdacyn60 eye care based on Sonoma’s patented Microcyn Technology. The formulation, marketed in the United States as Acuicyn Antimicrobial Eyelid and Eyelash Hygiene solution, is a safe and efficac
- HumanOptics Receives CE Mark for Trifocal Lens Triva-aAhttps://modernod.com/news/humanoptics-receives-ce-mark-for-trifocal-lens-triva-aa/2477310/HumanOptics AG has received CE marking and approval in the European market for its new trifocal lens Triva-aA. Triva-aA is the first multifocal lens from HumanOptics with three focal points. Its optimized design enables patients to enjoy good vision not only at long and near distances, but
- Implandata Gains CE Mark for its Eyemate System for Keratoprosthesishttps://modernod.com/news/implandata-gains-ce-mark-for-its-eyemate-system-for-keratoprosthesis/2476510/Ophthalmic sensors and digital health company Implandata Ophthalmic Products announced that it attained CE mark for its Eyemate system for use in patients undergoing keratoprosthesis surgery. Keratoprosthesis represents an infrequent yet important procedure for restoring vision. It is performed o
- Implandata Gains CE Mark for Next-Generation EyeMate Systemhttps://modernod.com/news/implandata-gains-ce-mark-for-next-generation-eyemate-system/2476411/Implandata Ophthalmic Products received CE mark approval for its next-generation EYEMATE-IO 1.1 implantable micro-sensor, which will be launched in April. The EYEMATE-IO enables eye surgeons to place the permanent implantable eye pressure sensor in conjunction with cataract surgery through signif
- Optimo Medical Receives CE Mark for Optimeyes Surgical Planning Toolhttps://modernod.com/news/optimo-medical-receives-ce-mark-for-optimeyes-surgical-planning-tool/2480233/Switzerland-based Optimo Medical AG announced that it has received CE Mark for Optimeyes as a Class 2b medical device. The Optimeyes software predicts in a patient-specific way the influence of physical interventions in the cornea, allowing it to simulate and evaluate treatment results in
- Belkin Vision's Automated, Non-Contact Glaucoma Laser Treatment Receives CE Markhttps://modernod.com/news/belkin-visions-eagle-receives-ce-mark-under-mdr/2480859/Israel-based Belkin Vision announced that it has received CE Mark for its Eagle device, making it the first automated, non-contact glaucoma laser treatment available within Europe. The CE Mark was granted under Medical Device Regulation (MDR) from its notified body DEKRA.